Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

What medical training can learn from placebo research

Karan Chhabra
Education
January 27, 2014
Share
Tweet
Share

Placebos work. This isn’t news. The term “placebo” was coined 60 years ago to describe how one-third of people respond to pills without any active drug in them. Twenty-five years later, we learned how they work: through endorphins produced by the body that work just like morphine. Today placebos are everywhere: from mothers kissing boo-boos to international drug trials.

A recent paper, though, shows that all placebos aren’t created equal. As expected, the authors found placebo pills effective for reducing migraines in about one-fifth of patients. But it gets better. Take sham acupuncture, which doesn’t target traditional pressure points and doesn’t penetrate the skin. Despite being “fake,” sham acupuncture reduced migraines in 38% of patients, making it as effective as real migraine drugs. The authors also studied sham surgery, in which doctors give anesthesia and cut the skin, but stitch it back together without doing anything to the tissues underneath. These fake operations helped 58% of migraine patients, potentially even more than active drugs.

What does this tell us? It depends on whom you ask. Some might say we need to figure out how to predict a good response to placebo (and are trying to do just that). Others might say we need to test more procedures against shams, to make sure they’re effective. Yet others might say sham surgery is unethical outright. These are questions without quick answers. For the rest of us, what can the placebo effect teach us about medicine as a whole?

No treatments — drugs, placebos, shams — exist in a vacuum. They’re part of a complex ritual of storytelling and listening, examining and touching, teaching and prescribing. Patients expect this ritual and I, like any medical student, am working to master it. Yesterday’s medicine might’ve been a prayer or a poultice; today’s it’s delivered on blue slips and under blue drapes. But one thing that hasn’t changed is that ailing humans want intervention. And the benefits of medicine transcend pills and procedures. Words, touch, and hope can be therapeutic.

Wielded inappropriately, they can do harm too. Medicine embraces lots of treatments without proven benefit. Many doctors still stent narrowed blood vessels in the heart when patients have stable chest pain, even though the right pills extend life just as much. (Stents do appear better at preventing pain – but is that another placebo effect?) Some patients with early prostate cancer are also receiving expensive proton beam therapy instead of conventional radiation, again without evidence of benefit. Some doctors may be recommending these treatments for the wrong reasons. But I imagine many are working to satisfy a basic human impulse: to act aggressively in the face of disease. Our bodies respond better to high-touch, high-tech interventions: we get more pain relief from a $2.50 placebo than one that costs a dime. But bigger is not always better. Bigger is often more likely to do harm, through costs or complications.

What I take away from placebo research is that how we do our job is just as important as what we do. The notion that drugs and surgery are the only treatment we can offer has become a self-fulfilling prophecy. Medical training and research are decidedly focused on what drugs to give when – knowledge necessary, but not sufficient, to serve our patients. This may distract us from the psychological and social mechanisms beneath the human response to treatment. Rather than inventing a new procedure that might not be more effective than sham, we should be inventing ways to get the benefits of a sham without cutting the skin.

Many of our most common yet most frustrating afflictions have a psychological component: for example back pain, irritable bowel syndrome, and of course headaches. So it makes sense that these conditions have been shown again and again to respond to the placebo effect. It’s now our duty to figure out how we can put that power to good use. What combination of advice, empathy, and touch unlocks our body’s natural painkillers? Can we be high-touch without being high-tech? Can that be taught? Experienced clinicians may have the answer without even knowing it. But students like myself could use a bit more training on how to be our patients’ placebos.

I’m not referring to prescribing placebos, though some are trying to figure out how to do so without deception. We must learn how to make a patient’s body expect relief without the scalpel, needle, or prescription pad. Are there questions that make a patient feel heard, exam maneuvers that show I’m paying attention? When there’s no medical answer, can words themselves heal? After years and years of training, is there something I can do that pills cannot?

Karan Chhabra is a medical student who blogs at Project Millenial. He can be reached on Twitter @KRChhabra. This article originally appeared in the Boston Globe’s Short White Coat.

Prev

Be emotionally intimate with your patients

January 27, 2014 Kevin 195
…
Next

Invite a primary care physician to the State of the Union

January 27, 2014 Kevin 0
…

Tagged as: Medical school

Post navigation

< Previous Post
Be emotionally intimate with your patients
Next Post >
Invite a primary care physician to the State of the Union

ADVERTISEMENT

More by Karan Chhabra

  • Sometimes high-tech care can be high value

    Karan Chhabra
  • a desk with keyboard and ipad with the kevinmd logo

    What have we lost with the progress of medical training?

    Karan Chhabra
  • a desk with keyboard and ipad with the kevinmd logo

    Can high-tech medicine also be high value?

    Karan Chhabra

More in Education

  • Why visitor bans hurt patient care

    Emmanuel Chilengwe
  • Why we need to expand Medicaid

    Mona Bascetta
  • How to succeed in your medical training

    Jessica Favreau, MD
  • The crisis of physician shortages globally

    Samah Khan
  • Stop doing peer reviews for free

    Vijay Rajput, MD
  • How AI is changing medical education

    Kelly Dórea França
  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Why bad math (not ideology) is killing DPC clinics [PODCAST]

      The Podcast by KevinMD | Podcast
    • Finding your child’s strengths: a new mindset

      Suzanne Goh, MD | Conditions
    • A new vision for modern, humane clinics

      Miguel Villagra, MD | Physician
    • The night of an impalement injury surgery

      Xiang Xie | Conditions
    • Medicine’s silence on RFK Jr. [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • Silicon Valley’s primary care doctor shortage

      George F. Smith, MD | Physician
  • Recent Posts

    • Why bad math (not ideology) is killing DPC clinics [PODCAST]

      The Podcast by KevinMD | Podcast
    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
    • Did the CDC just dismantle vaccine safety clarity?

      Ronald L. Lindsay, MD | Policy
    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Why bad math (not ideology) is killing DPC clinics [PODCAST]

      The Podcast by KevinMD | Podcast
    • Finding your child’s strengths: a new mindset

      Suzanne Goh, MD | Conditions
    • A new vision for modern, humane clinics

      Miguel Villagra, MD | Physician
    • The night of an impalement injury surgery

      Xiang Xie | Conditions
    • Medicine’s silence on RFK Jr. [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • Silicon Valley’s primary care doctor shortage

      George F. Smith, MD | Physician
  • Recent Posts

    • Why bad math (not ideology) is killing DPC clinics [PODCAST]

      The Podcast by KevinMD | Podcast
    • Glioblastoma immunotherapy trial: a new breakthrough

      Hoag Memorial Hospital Presbyterian | Conditions
    • Did the CDC just dismantle vaccine safety clarity?

      Ronald L. Lindsay, MD | Policy
    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

What medical training can learn from placebo research
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...